Infliximab
Product Approval Information - Licensing Action
Proper name: Infliximab
Tradename: Remicade
Manufacturer: Centocor Inc, Malvern, PA, License #1242
Expanded Indication for Use: Inhibition of progression of structural damage in patients with rheumatoid arthritis who have had an inadequate response to methotrexate
Approval Date: 12/29/2000
Type of submission: Biologics license supplement
Approval Letter (Text), (PDF)
Label (PDF)
Last Updated: 3/5/2001
Back
to Top
Back to Index
Updated: September 25, 2003 |